TABLE 1.
Drug(s) | MIC for indicated strain (μg/ml)
|
Interpretationb | |||||
---|---|---|---|---|---|---|---|
FI-06102 | FI-07062 | FI-07154 | FI-08110 | FI-08139 | FI-08141 | ||
Amikacin | 16 | 32 | 16 | 32 | 32 | 32 | S/I |
Ciprofloxacin | >16 | >16 | >16 | >16 | >16 | >16 | R |
Clarithromycin | 1 | 0.5 | 0.5 | 1 | 1 | 1 | S |
Ethambutol | 16 | >32 | 16 | 32 | 16 | 32 | R |
Gatifloxacin | 8 | >8 | >8 | >8 | >8 | >8 | R |
Linezolid | 8 | 8 | 8 | 16 | 16 | 16 | S/I |
Minocycline | 8 | 16 | 8 | 16 | 16 | 16 | I/R |
Moxifloxacin | 2 | 4 | 4 | 8 | 8 | 4 | R |
Rifabutin | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | S |
Rifampin | 0.5 | 1 | 0.5 | 1 | 1 | 1 | S |
Streptomycin | 32 | 32 | 32 | 32 | 64 | 32 | R |
Trimethoprim-sulfamethoxazole | >152 | >152 | 152 | 152 | >152 | >152 | R |
Only one strain was tested of the two strains suspected to result from a cross-contamination.
S, susceptible; R, resistant; I, intermediate.